Clinical trial · Interventional
Comorbidities And Reducing inEquitieS
Multi-level Interventions to Manage Co-morbidities Among Black Breast and Prostate Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Black cancer patients tend to have worse outcomes than White cancer patients. Some of this disparity may be due to comorbidities. The purpose of this study is to improve management of co-morbidities among cancer patients in order to improve cancer outcomes and improve health equity. Comorbidities such as diabetes and hypertension can complicate cancer treatment or can make it difficult to reach optimal health after treatment. This study will offer additional support and tools to manage cancer patient's health needs. First, the study will use a mobile health application, managed by a company called Welldoc, to monitor patient progress in real time and to provide ongoing guidance. Second, the study will connect patients with a Community Health Worker who will speak with them weekly to discuss self-care information, including medical scheduling or appointment needs, and assist with daily self-monitoring of blood pressure and/or blood glucose monitoring. Lastly, an oncology nurse will monitor reported health and triage any medical needs and whether additional medical care is needed.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Breast | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Cancer Prostate | — | UNRESOLVED | — |
| Diabetes Mellitus | — | UNRESOLVED | — |
| Hypertension | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Support | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Will receive mHealth support for comorbidity and support from a Community Health Worker by phone
- interventionNames
- Behavioral: Support
Primary outcomes (3)
- measure
- Feasibility of study protocol
- timeFrame
- Study recruitment period will be approximately 12 months
- description
- Accrual of \>50 patients into the study
- measure
- Feasibility of an active management strategy for comorbidities
- timeFrame
- Study duration will be 6 months for prostate cancer patients and duration of treatment plus one month for breast cancer patients (approximately 7 months)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Black women with a diagnosis of stage 0-IV breast cancer and within a month of treatment initiation or with 6+ months of treatment left OR Black men with a history of prostate cancer who are on long-term androgen deprivation therapy; * Blood pressure \>=120/80 OR diagnosis of diabetes * Individuals who develop these conditions during treatment such as those scheduled to initiate steroid-containing chemotherapy or targeted PI3K inhibitor therapies * Access to a smartphone and/or internet for the duration of the study. * Can understand and communicate in English Exclusion Criteria: \- Unwilling to participate in a 6-month study
References
Publications (1)
- DERIVEDSchubel L, Mete M, Fong A, Boxley C, Barac A, Gallagher C, Magee MF, Arem H. Understanding Perceptions of Care Coordination and Chronic Illness Management among Black Breast and Prostate Cancer Survivors and Providers: Findings from a Quality Improvement Study. J Ambul Care Manage. 2024 Oct-Dec 01;47(4):228-238. doi: 10.1097/JAC.0000000000000505. Epub 2024 Aug 23. PMID 39028275